This paper had publication bias, more high-quality clinical trials and further research on the mechanism of MALAT-1 in NSCLC are needed to provide more convincing evidence for exploring the relationship between MALAT-1 and prognosis of NSCLC. The gene discussed is MALAT1; the disease is non-small cell lung carcinoma.